Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FM3Z1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,045
Award facts
- Contract value 100% obligated
- $70,045.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $70,045.21 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on November 17, 2025. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Zepbound is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, reflecting the federal government's commitment to providing modern pharmaceutical treatments through its medical supply chain.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26FM3Z1?
SPE2DR26FM3Z1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FM3Z1 worth?
The government has obligated $70,045 on SPE2DR26FM3Z1.
Is contract SPE2DR26FM3Z1 an order under another contract?
Yes. SPE2DR26FM3Z1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM3Z1 competed?
The extent of competition for SPE2DR26FM3Z1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award